CHINA MEHECO GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.9 CNY | -0.27% |
|
-3.63% | -2.42% |
| Feb. 20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
| Feb. 20 | Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation | MT |
| Sales 2021 | 36.23B 5B | Sales 2022 | 37.59B 5.19B | Capitalization | 25.77B 3.56B |
|---|---|---|---|---|---|
| Net income 2021 | 647M 89.29M | Net income 2022 | 736M 102M | EV / Sales 2021 | 0.4 x |
| Net Debt 2021 | 1.88B 259M | Net Debt 2022 | 1.09B 150M | EV / Sales 2022 | 0.71 x |
| P/E ratio 2021 |
19.5
x | P/E ratio 2022 |
35
x | Employees | 8,313 |
| Yield 2021 |
1.54% | Yield 2022 |
0.86% | Free-Float | 44.6% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.55% | ||
| 1 week | -3.36% | ||
| Current month | -0.73% | ||
| 1 month | -1.53% | ||
| 3 months | +7.37% | ||
| 6 months | -3.95% | ||
| Current year | -2.15% |
1 week
10.76
11.25
1 month
10.4811.63
Current year
9.7812.24
1 year
9.7815.50
3 years
7.4031.61
5 years
7.4031.61
10 years
6.9531.61
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Dong Hu
CEO | Chief Executive Officer | 48 | 21-09-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Min Zhang
BRD | Director/Board Member | 62 | 22-08-17 |
Yong Qiang
CHM | Chairman | 58 | 09-09-14 |
Shao Feng Zhang
BRD | Director/Board Member | 46 | Dec. 20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.47% | 2 M€ | -19.10% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 10.9 | -0.27% | 7 771 089 |
| 24-04-24 | 10.93 | +0.55% | 9,503,658 |
| 24-04-23 | 10.87 | -1.27% | 10,942,310 |
| 24-04-22 | 11.01 | -1.52% | 14,716,340 |
| 24-04-19 | 11.18 | +0.09% | 13,895,680 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -2.15% | 2.26B | |
| +15.93% | 70.36B | |
| +3.00% | 25.18B | |
| +6.36% | 8.61B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| -0.37% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -3.44% | 3.87B |
- Stock Market
- Equities
- 600056 Stock
